glp 1 crackdown Why the FDA is cracking down on compound GLP-1 drugs for weight loss Rising Costs Cited by 68%

J., Bajaj, M., Bannuru, R

Plenty of water is essential, too, because the drugs also diminish a person's sense of thirst

50 A recent meta-analysis including thirteen RCTs has shown that semaglutide and tirzepatide treatment significantly increases GI side effects such as nausea, vomiting, diarrhea, and constipation in obese individuals without diabetes compared to control groups

Our commitment to safe GLP-1 prescribing begins with understanding that these medicines are not cosmetic treatments or quick fixes

Already have an account

While most people tolerate them well, its helpful to know what side effects to expect, especially in the first few weeks of treatment: nausea vomiting diarrhea constipation headaches fatigue These symptoms are well-documented across clinical trials and often appear during the dose escalation phase